act securing quality efficacy safety products including pharmaceuticals medical devices iyakuhin iryōkiki tō hinshitsu yūkōsei oyobi anzensei kakuho tō ni kansuru hō ritsu law regulating manufacturing importation sale drugs medical devices medical softwares originally passed pharmaceutical affairs act 薬事法 yakujihō renamed current title often abbreviated iyakuhin iryōkiki tō hō 医薬品医療機器等法 yakki hō 薬機法 july amendment law changed regulatory structure pharmaceuticals medical devices effort align laws closely european union australia canada united states amendment shifted focus regulation point manufacturing point sale adopted riskbased classification system june amendment law law effective date june represented first change sales structure otc drugs amended law permitted stores sell certain overthecounter drugs without pharmacist staff opening market convenience stores supermarkets stores first convenience store take advantage amended law aeon supermarkets also began selling otc drugs discount competing drug stores including aeonaffiliated companies amendment expected put significant competitive pressure drug stores however law continued ban internet sales otc drugs ministry health previously justified stating drug sales conducted person pharmacists qualified vendors could explain side effects may government cabinet approved revision pharmaceutical affairs law simplify approval process medical devices regenerative medicine products safety regenerative medicine using ips cells stem cells according revised bill medical equipment checked private organization including regenerative medicine products validation postmarketing